Literature DB >> 14631586

[Risk and benefits of hormone replacement therapy by postmenopausal women. WHI-Study].

V Heinemann1, K Parhofer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14631586     DOI: 10.1007/s00108-003-0985-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  4 in total

1.  Postmenopausal hormone therapy and cardiovascular disease.

Authors:  C Otto; K Parhofer
Journal:  Ann Intern Med       Date:  2001-12-18       Impact factor: 25.391

2.  Hormone replacement therapy and increased plasma concentration of C-reactive protein.

Authors:  P M Ridker; C H Hennekens; N Rifai; J E Buring; J E Manson
Journal:  Circulation       Date:  1999-08-17       Impact factor: 29.690

3.  Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

Authors:  Stephen Hulley; Curt Furberg; Elizabeth Barrett-Connor; Jane Cauley; Deborah Grady; William Haskell; Robert Knopp; Maureen Lowery; Suzanne Satterfield; Helmut Schrott; Eric Vittinghoff; Donald Hunninghake
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272

4.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.